NCT02460978 Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes Status COMPLETED Phase PHASE3
NCT02459990 Congenital Malformations and Maternal Use of Anti-hypertensive Medication in the United Kingdom Status COMPLETED Phase N/A
NCT02457130 Comparison of TIcagrelor and Clopidogrel in Patients With Coronary Artery diseaSe and Type 2 Diabetes Mellitus (TICS-DM) Status UNKNOWN Phase PHASE4
NCT02454933 Study of AZD9291 Plus MEDI4736 Versus AZD9291 Monotherapy in NSCLC After Previous EGFR TKI Therapy in T790M Mutation Positive Tumours Status COMPLETED Phase PHASE3
NCT02453282 Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02450656 Afatinib and Selumetinib in Advanced KRAS Mutant and PIK3CA Wildtype Non-small Cell Lung Cancer Status UNKNOWN Phase PHASE1/PHASE2
NCT02449473 Study to Evaluate Efficacy & Safety of Tralokinumab in Subjects With Asthma Inadequately Controlled on Corticosteroids Status COMPLETED Phase PHASE2
NCT02447328 A Single Arm, Tolerability and Safety Phase IV Study of Fulvestrant(Faslodex® ) as 2nd Line and Later Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer Status COMPLETED Phase PHASE4
NCT02446912 Efficacy and Safety of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus Status COMPLETED Phase PHASE3
NCT02446899 Efficacy and Safety of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus Status COMPLETED Phase PHASE3
NCT02446704 Study of Olaparib and Temozolomide in Patients With Recurrent Small Cell Lung Cancer Following Failure of Prior Chemotherapy Status UNKNOWN Phase PHASE1/PHASE2
NCT02446600 Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02446171 A Bioavailability Study With Alternate Methods of Administration of Naloxegol Tablets, and Solution Status COMPLETED Phase PHASE1
NCT02442349 Phase II Single Arm Study of AZD9291 to Treat NSCLC Patients in Asia Pacific Status COMPLETED Phase PHASE2
NCT02436577 Study to Assess the Bioequivalence Between Ticagrelor Orodispersible Tablets and Ticagrelor Immediate-release Tablets in Japanese Subjects Status COMPLETED Phase PHASE1
NCT02434497 A Study to Evaluate the Safety of Rosuvastatin in Children and Adolescents With Homozygous Familial Hypercholesterolemia Status COMPLETED Phase PHASE3